Press Release Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide Zealand Pharma · Aug 12
Press Release Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Journey Medical Corporation · Aug 12
Press Release Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants Outlook Therapeutics, Inc. · Aug 12
Press Release Byrna Appoints Retired U.S. Army Brigadier General Rose Lopez Keravuori to Board of Directors Byrna Technologies, Inc. · Aug 12
Press Release Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update Allogene Therapeutics, Inc. · Aug 12
Press Release SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates SeaStar Medical · Aug 12
Press Release Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update Spero Therapeutics, Inc. · Aug 12
Press Release Resideo Announces Record Second Quarter 2026 Financial Results; Initiates Standalone 2026 Outlook Resideo Technologies, Inc. · Aug 12
Press Release BioStem Technologies Reports Second Quarter 2026 Financial Results BioStem Technologies, Inc. · Aug 12
Press Release Global Crossing Airlines Reports Second Quarter 2026 Financial Results Global Crossing Airlines Group Inc. · Aug 12